Literature DB >> 12013157

Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary.

Sophie Camatte1, Philippe Morice, Patricia Pautier, David Atallah, Pierre Duvillard, Damienne Castaigne.   

Abstract

OBJECTIVE: To assess the fertility of patients treated conservatively for a Stage II or III borderline ovarian tumour.
DESIGN: A retrospective study.
SETTING: Gynaecological oncology department in a French anti-cancer centre. POPULATION: Seventeen patients treated with conservative management for a Stage II (n = 6) or III (n = 11) borderline ovarian tumour were followed up. Fifteen patients underwent a unilateral salpingo-oophorectomy (with contralateral cystectomy in six patients), one had unilateral cystectomy and one a bilateral cystectomy. Fourteen patients had non-invasive implants and three had invasive implants. MAIN OUTCOME MEASURES: Pregnancy rates and outcome.
RESULTS: Eight pregnancies were observed in seven patients in a median delay of eight months following the surgical procedure. Six pregnancies were observed spontaneously, one occurred after an ovarian stimulation and one after an IVF procedure. None of these patients recurred under the form of invasive ovarian carcinoma on the spared ovary. Two patients (one with a non-invasive disease and one with an invasive one) had recurrence in the form of evolutive invasive implants, but neither woman died.
CONCLUSION: Spontaneous pregnancy can occur after conservative treatment of advanced stage borderline tumour of the ovary (with non-invasive implants). Such management, performed in a close follow up of the patients, does not affect the overall survival. Conservative surgery could be proposed in patients with borderline tumour of the ovary and non-invasive peritoneal implants.

Entities:  

Mesh:

Year:  2002        PMID: 12013157     DOI: 10.1111/j.1471-0528.2002.01359.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  11 in total

Review 1.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

Review 2.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

3.  Risk factors for recurrence of ovarian borderline tumors.

Authors:  K K Shih; Q Zhou; J Huh; J C Morgan; A Iasonos; C Aghajanian; D S Chi; R R Barakat; N R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2010-12-10       Impact factor: 5.482

4.  Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.

Authors:  Karin K Shih; Qin C Zhou; Carol Aghajanian; Jae Huh; Robert A Soslow; Jessica C Morgan; Alexia Iasonos; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2010-08-16       Impact factor: 5.482

5.  A meta-analysis on the impact of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors with invasive implants.

Authors:  Ines Vasconcelos; Jessica Olschewski; Ioana Braicu; Jalid Sehouli
Journal:  Oncologist       Date:  2015-01-19

Review 6.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

7.  The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.

Authors:  Chenyan Fang; Lingqin Zhao; Xi Chen; Aijun Yu; Liang Xia; Ping Zhang
Journal:  BMC Cancer       Date:  2018-11-21       Impact factor: 4.430

8.  Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.

Authors:  Ziyang Lu; Bin Li; Chao Gu
Journal:  J Int Med Res       Date:  2019-08-21       Impact factor: 1.671

9.  Identification of clinical and molecular features of recurrent serous borderline ovarian tumour.

Authors:  Ziyang Lu; Fanghe Lin; Tao Li; Jinhui Wang; Cenxi Liu; Guangxing Lu; Bin Li; MingPei Pan; Shaohua Fan; Junqiu Yue; He Huang; Jia Song; Chao Gu; Jin Li
Journal:  EClinicalMedicine       Date:  2022-04-08

10.  Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment.

Authors:  Chan Woo Park; Kwang Moon Yang; Hye Ok Kim; Sung Ran Hong; Tae Jin Kim; Kyung Taek Lim; Ki Heon Lee; Inn Soo Kang
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.